HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

Equity investor buys into Schiff Nutrition

You may also be interested in...



Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden

Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.

News In Brief

ActivOn buy puts Surya in U.S. OTC arena

FDA Criminal Probe Of Nic Lite Seller Should Be Considered – Public Citizen

Public Citizen is asking FDA to consider whether criminal prosecution of Nico Worldwide is an appropriate response to the firm's continued marketing of its nicotine water product Nic Lite as a dietary supplement

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel